Involvement of p53 and p21 in Cellular Defects and Tumorigenesis in Atm^(−/−) Mice
Abstract
Disruption of the mouse Atm gene, whose human counterpart is consistently mutated in ataxia-telangiectasia (A-T) patients, creates an A-T mouse model exhibiting most of the A-T-related systematic and cellular defects. While ATM plays a major role in signaling the p53 response to DNA strand break damage, Atm-/- p53-/- mice develop lymphomas earlier than Atm-/- or p53-/- mice, indicating that mutations in these two genes lead to synergy in tumorigenesis. The cell cycle G1/S checkpoint is abolished in Atm-/- p53-/- mouse embryonic fibroblasts (MEFs) following gamma -irradiation, suggesting that the partial G1 cell cycle arrest in Atm-/- cells following gamma -irradiation is due to the residual p53 response in these cells. In addition, the Atm-/- p21-/- MEFs are more severely defective in their cell cycle G1 arrest following gamma -irradiation than Atm-/- and p21-/- MEFs. The Atm-/- MEFs exhibit multiple cellular proliferative defects in culture, and an increased constitutive level of p21 in these cells might account for these cellular proliferation defects. Consistent with this notion, Atm-/- p21-/- MEFs proliferate similarly to wild-type MEFs and exhibit no premature senescence. These cellular proliferative defects are also rescued in Atm-/- p53-/- MEFs and little p21 can be detected in these cells, indicating that the abnormal p21 protein level in Atm-/- cells is also p53 dependent and leads to the cellular proliferative defects in these cells. However, the p21 mRNA level in Atm-/- MEFs is lower than that in Atm+/+ MEFs, suggesting that the higher level of constitutive p21 protein in Atm-/- MEFs is likely due to increased stability of the p21 protein.
Additional Information
© 1998, American Society for Microbiology. Received 10 March 1998/Accepted 13 April 1998 This project was partially supported by a National Institute of Health grant to D.B. and grants from AT Childrens Projects to D.B. and Y.X. Y.X. was partly supported by the Cancer Research Fund of the Damon Runyon-Walter Winchell Foundation. D.B. is an American Cancer Society Research Professor.Attached Files
Published - XUYmcb98.pdf
Files
Name | Size | Download all |
---|---|---|
md5:3abcd97820a4209d62d1e4cb774538c5
|
381.1 kB | Preview Download |
Additional details
- PMCID
- PMC109022
- Eprint ID
- 2815
- Resolver ID
- CaltechAUTHORS:XUYmcb98
- NIH
- Ataxia Telangiectasia
- Damon Runyon-Walter Winchell Cancer Fund
- American Cancer Society
- Created
-
2006-04-28Created from EPrint's datestamp field
- Updated
-
2021-11-08Created from EPrint's last_modified field